Delivery Order SPE2DB24D3013-SPE2DB26FFGJA
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,608.41 by the Defense Logistics Agency on April 29, 2025, with an ultimate completion date of April 30, 2025. The award covers Trelegy Ellipta 200-62.5-25, a combination respiratory medication used for chronic obstructive pulmonary disease and asthma management. This is a firm fixed-price delivery order with no set-aside designation, issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for TRELEGY ELLIPTA 100-62.5-25 (60 count) by the Defense Logistics Agency on September 8, 2025. The award carries a ceiling value of $1,441.50 and represents a firm fixed price delivery order with no set-aside designation, indicating competitive selection among qualified vendors. This child contract is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $14,902.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of October 29, 2025. This is a firm fixed-price, non-set-aside contract executed on October 28, 2025, with performance at the company's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,017.78 by the Defense Logistics Agency on July 18, 2025, with an ultimate completion date of July 21, 2025. The delivery order, issued under a firm fixed-price contract type with no set-aside designation, covers the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used in treating chronic obstructive pulmonary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 16, 2025, for TRELEGY ELLIPTA 100-62.5-25, a respiratory medication, in the amount of $1,251.90. The delivery order is firm fixed price with an ultimate completion date of September 17, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,163.18 by the Defense Logistics Agency (DLA) on November 3, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 in a 60-dose configuration. This firm fixed-price delivery order, which is not set-aside, has an ultimate completion date of November 4, 2025, and represents a child contract action under a larger indefinite delivery vehicle. The award was competitively issued, reflecting...
- The Defense Logistics Agency awarded a $33,190.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory medication supplied in a 60-dose inhaler format. This non-set-aside competitive award was executed on August 28, 2025, with an ultimate completion date of August 29, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a relatively modest transaction within the...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp for $5,699.88 to supply Trelegy Ellipta 100-62.5-25 (a combination respiratory medication) with an ultimate completion date of September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at...
- The Defense Logistics Agency awarded a delivery order valued at $63,304.11 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication delivered in a 60-dose package. The contract, issued on September 11, 2025, with completion targeted for September 12, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $3,736.05, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The delivery order has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFGJADelivery Order
The Defense Logistics Agency awarded a $6,846.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with performance in Conshohocken, Pennsylvania and completion targeted for November 13, 2025. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, consistent with AmerisourceBergen's established track record of meeting federal pharmaceutical procurement requirements through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical supply needs across military and veteran healthcare systems. The broader IDC vehicle enables the company to supply an extensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates significant capability in fulfilling diverse medical commodity requirements, ranging from specialty medications and vaccines to medical devices and test kits across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 11/12/25 |